COMMUNIQUÉS West-GlobeNewswire
-
Keros Therapeutics Appoints Anne Prener to its Board of Directors
25/06/2026 -
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026
25/06/2026 -
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
25/06/2026 -
Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026
25/06/2026 -
Medical Practice Pay Cools, But Hiring Pressure Holds Firm, New MGMA Report Finds
25/06/2026 -
BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
25/06/2026 -
JellyFil Discloses 2026 Botanical Ingredient Sourcing, cGMP Manufacturing Standards, Caffeine Content, and Consumer Safety Considerations for Its Premium Gummy Dietary Supplement
25/06/2026 -
Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada
25/06/2026 -
Xealth Survey Defines Digital Readiness Gaps Between Healthcare Executives and Physicians
25/06/2026 -
First Stop Health Enhances Healthy Weight Program amid Growing GLP-1 Employee Demand and Employer Costs
25/06/2026 -
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale
25/06/2026 -
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026 -
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
25/06/2026 -
Regenix Labs Announces Educational Guide on NAD+, Cellular Energy, and Healthy Aging
25/06/2026 -
Valneva Announces Successful Outcome of its Annual General Meeting
25/06/2026 -
Two of Canada’s top athletes named Canadian Red Cross monthly giving ambassadors
25/06/2026 -
Deux athlètes d’élite du Canada deviennent ambassadeurs du programme de dons mensuels de la Croix-Rouge canadienne
25/06/2026 -
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026 -
Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates
25/06/2026
Pages